These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 33546886)

  • 1. The challenges of insecurity on implementing vaccination campaign and its effect on measles elimination and control efforts: A case study of 2017/18 measles campaign in Borno state, Nigeria.
    Babakura B; Nomhwange T; Jean Baptiste AE; Dede O; Taiwo L; Abba S; Soyemi M; Idowu AM; Terna Richard M; Braka F; Oteri J; Shuaib F
    Vaccine; 2021 Nov; 39 Suppl 3():C66-C75. PubMed ID: 33546886
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Measles outbreak in complex emergency: estimating vaccine effectiveness and evaluation of the vaccination campaign in Borno State, Nigeria, 2019.
    Jean Baptiste AE; Wagai J; Luce R; Masresha B; Klinkenberg D; Veldhuijzen I; Oteri J; Dieng B; Ikeonu OC; Meleh S; Musa A; Braka F; Hahné S; Sanders EAM; Hak E
    BMC Public Health; 2021 Mar; 21(1):437. PubMed ID: 33663439
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Internal displacement; an impediment to the successful implementation of planned measles supplemental activities in Nigeria, a case study of Benue State.
    Korave J; Bawa S; Ageda B; Ucho A; Bem-Bura DM; Onimisi A; Dieng B; Nsubuga P; Oteri J; Fiona B; Shuaib F
    Vaccine; 2021 Nov; 39 Suppl 3():C76-C81. PubMed ID: 33461836
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Measles outbreak response immunization during the COVID-19 pandemic: lessons from Borno State, Nigeria.
    Nomhwange T; Mohammed A; Jean Baptiste AE; Musa A; Yusuf A; Yusuf M; Wagai J; Shettima A; Meleh S; Banda R; Braka F; Luce R; Masresha B
    Pan Afr Med J; 2022; 41():104. PubMed ID: 35432705
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The reactive vaccination campaign against cholera emergency in camps for internally displaced persons, Borno, Nigeria, 2017: a two-stage cluster survey.
    Ngwa MC; Alemu W; Okudo I; Owili C; Ugochukwu U; Clement P; Devaux I; Pezzoli L; Oche JA; Ihekweazu C; Sack DA
    BMJ Glob Health; 2020 Jun; 5(6):. PubMed ID: 32601092
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Application of the Geographic Information System (GIS) in immunisation service delivery; its use in the 2017/2018 measles vaccination campaign in Nigeria.
    Oteri J; Idi Hussaini M; Bawa S; Ibizugbe S; Lambo K; Mogekwu F; Wiwa O; Seaman V; Kolbe-Booysen O; Braka F; Nsubuga P; Shuaib F
    Vaccine; 2021 Nov; 39 Suppl 3():C29-C37. PubMed ID: 33478790
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nigeria experience on the use of polio assets for the 2017/18 measles vaccination campaign follow-up.
    Oteri AJ; Adamu U; Dieng B; Bawa S; Terna N; Nsubuga P; Owoaje ET; Kassogue M; Jean Baptiste AE; Braka F; Shuaib F
    Vaccine; 2021 Nov; 39 Suppl 3():C3-C11. PubMed ID: 33962837
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Planning for supplemental immunization activities using the readiness assessment dashboard: Experience from 2017/2018 Measles vaccination campaign, Nigeria.
    Terna Richard M; Taiwo L; Jean Baptiste AE; Bawa S; Dieng B; Wiwa O; Lambo K; Braka F; Shuaib F; Oteri J
    Vaccine; 2021 Nov; 39 Suppl 3():C21-C28. PubMed ID: 34247903
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Using data to improve outcomes of supplemental immunisation activities: 2017/2018 Nigeria measles vaccination campaign.
    Mogekwu FI; Oteri JA; Nsubuga P; Ezebilo O; Maxwell N; Wiwa O; Braka F; Shuaib F
    Vaccine; 2021 Nov; 39 Suppl 3():C38-C45. PubMed ID: 33461831
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mass immunization with inactivated polio vaccine in conflict zones--Experience from Borno and Yobe States, North-Eastern Nigeria.
    Shuaibu FM; Birukila G; Usman S; Mohammed A; Galway M; Corkum M; Damisa E; Mkanda P; Mahoney F; Wa Nganda G; Vertefeuille J; Chavez A; Meleh S; Banda R; Some A; Mshelia H; Umar AU; Enemaku O; Etsano A
    J Public Health Policy; 2016 Feb; 37(1):36-50. PubMed ID: 26538455
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Geographical and time trends of measles incidence and measles vaccination coverage and their correlation in Nigeria.
    Sato R; Makinde OA; Daam KC; Lawal B
    Hum Vaccin Immunother; 2022 Nov; 18(6):2114697. PubMed ID: 36041074
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Finding inhabited settlements and tracking vaccination progress: the application of satellite imagery analysis to guide the immunization response to confirmation of previously-undetected, ongoing endemic wild poliovirus transmission in Borno State, Nigeria.
    Higgins J; Adamu U; Adewara K; Aladeshawe A; Aregay A; Barau I; Berens A; Bolu O; Dutton N; Iduma N; Jones B; Kaplan B; Meleh S; Musa M; Wa Nganda G; Seaman V; Sud A; Vouillamoz S; Wiesen E
    Int J Health Geogr; 2019 May; 18(1):11. PubMed ID: 31096971
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Measles resurgence following a nationwide measles vaccination campaign in Nigeria, 2005-2008.
    Weldegebriel GG; Gasasira A; Harvey P; Masresha B; Goodson JL; Pate MA; Abanida E; Chevez A
    J Infect Dis; 2011 Jul; 204 Suppl 1():S226-31. PubMed ID: 21666165
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modeling Poliovirus Transmission in Borno and Yobe, Northeast Nigeria.
    Kalkowska DA; Franka R; Higgins J; Kovacs SD; Forbi JC; Wassilak SGF; Pallansch MA; Thompson KM
    Risk Anal; 2021 Feb; 41(2):289-302. PubMed ID: 32348621
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adverse events following immunization: Findings from 2017/2018 measles vaccination campaign, Nigeria AEFI reporting in 2017/2018 measles vaccination campaign.
    Gbenewei E; Nomhwange T; Taiwo L; Ayodeji I; Yusuf K; Jean Baptiste AE; Nsubuga P; Braka F; Oteri J; Shuaib F
    Vaccine; 2021 Nov; 39 Suppl 3():C82-C88. PubMed ID: 33714655
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Continued Endemic Wild Poliovirus Transmission in Security-Compromised Areas - Nigeria, 2016.
    Nnadi C; Damisa E; Esapa L; Braka F; Waziri N; Siddique A; Jorba J; Nganda GW; Ohuabunwo C; Bolu O; Wiesen E; Adamu U
    MMWR Morb Mortal Wkly Rep; 2017 Feb; 66(7):190-193. PubMed ID: 28233765
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Geospatial variation in measles vaccine coverage through routine and campaign strategies in Nigeria: Analysis of recent household surveys.
    Utazi CE; Wagai J; Pannell O; Cutts FT; Rhoda DA; Ferrari MJ; Dieng B; Oteri J; Danovaro-Holliday MC; Adeniran A; Tatem AJ
    Vaccine; 2020 Mar; 38(14):3062-3071. PubMed ID: 32122718
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of an Intervention to Use a Measles, Rubella, and Polio Mass Vaccination Campaign to Strengthen Routine Immunization Services in Nepal.
    Wallace AS; Bohara R; Stewart S; Subedi G; Anand A; Burnett E; Giri J; Shrestha J; Gurau S; Dixit S; Rajbhandari R; Schluter WW
    J Infect Dis; 2017 Jul; 216(suppl_1):S280-S286. PubMed ID: 28838201
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Field challenges to measles elimination in the Democratic Republic of the Congo.
    Coulborn RM; Nackers F; Bachy C; Porten K; Vochten H; Ndele E; Van Herp M; Bibala-Faray E; Cohuet S; Panunzi I
    Vaccine; 2020 Mar; 38(13):2800-2807. PubMed ID: 32111528
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Measles outbreaks and Supplemental Immunization Activities (SIAs): the Gwagwalada experience, Abuja 2015.
    Olugbade OT; Adeyemi AS; Adeoti AH; Ilesanmi OS; Gidado SO; Waziri NE; Aworh MK
    Pan Afr Med J; 2019; 32(Suppl 1):10. PubMed ID: 30949285
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.